Response to Open Peer Commentaries on “Assessing the Likely Harms to Kidney Vendors in Regulated Organ Markets”
2014; 14(10): W1-W3
I am grateful for the thoughtfulness of the open peer commentaries, and regret that I cannot reply to them all in this brief response. My focus here is on the arguments raised concerning the available data from Iran, the possibility of addressing harms through regulation, the desirability of pilot studies, and the importance of allowing markets in order to respect vendors’ autonomy...
Read the complete article here at the American Journal of Bioethics (subscription required).